ロード中...
Drug resistance mechanisms in Japanese anaplastic lymphoma kinase‐positive non–small cell lung cancer and the clinical responses based on the resistant mechanisms
The treatment for anaplastic lymphoma kinase (ALK)‐positive lung cancer has been rapidly evolving since the introduction of several ALK tyrosine kinase inhibitors (ALK‐TKI) in clinical practice. However, the acquired resistance to these drugs has become an important issue. In this study, we collecte...
保存先:
| 出版年: | Cancer Sci |
|---|---|
| 主要な著者: | , , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley and Sons Inc.
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7060465/ https://ncbi.nlm.nih.gov/pubmed/31961053 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.14314 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|